Exosome RNA Exosome RNA Research & Industry News

Exostemtech said it applied for a phase 1 trial of EST-P-EXO1, an osteoarthritis treatment candidate, to the Food and Drug Safety Ministry. If the company gets the nod for the ...

A study demonstrated that vesicles released by red blood cells are a viable platform for delivering immunotherapeutic RNA molecules to suppress...

ILIAS Biologics Inc., a biotech company dedicated to developing a new treatment modality, engineered exosome therapeutics, announced today that it has...

Tumor associated macrophages (TAMs), which differentiate from circulating monocytes, are pervasive across human cancers and comprise heterogeneous populations. The contribution of tumor-derived signals to TAM heterogeneity is not well understood. ...

Researchers used exosomes produced by cells called adipose-derived mesenchymal stem cells (ADSCs) to deliver an RNA-based anti-cancer treatment...

Collaborative research from CMU yields a novel strategy that enables long-term spatial retention of extracellular vesicles, a key variable to enable future tissue engineering and regenerative medicine applications. Leveraging unique expertise in the spirit of...

To accurately identify the functions of tumour-cell-derived extracellular vesicles (T-EVs), EVs directly isolated from tumour tissues are much preferred over those derived from in vitro cultured tumour cell lines..

Nanoparticles can acquire a plasma protein corona defining their biological identity. Corona functions were previously considered for cell-derived extracellular vesicles (EVs). Researchers at...

Acute ischaemic stroke (AIS) is a leading cause of death and disability. MicroRNAs (miRNAs) are short non-coding RNAs which hold the potential to act as...